These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25445892)

  • 1. Elevated Lipoprotein(a) has Incremental Prognostic Value in Type 2 Diabetic Patients with Symptomatic Coronary Artery Disease.
    Kwon SW; Kim JY; Sung JM; Yoon YW; Rhee JH; Lee BK; Jung YH; Kim KH; Cha JJ; Park JK; Choi EY; Hong BK; Rim SJ; Kwon HM
    J Atheroscler Thromb; 2015; 22(5):527-34. PubMed ID: 25445892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.
    Shahid HS; Kurdi MI; Zohair AA
    Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Prognostic Value of Lipoprotein(a) in Symptomatic Patients With Nonobstructive Coronary Artery Disease.
    Xie H; Chen L; Liu H; Cui Y; Zhang Z; Cui L
    Am J Cardiol; 2017 Apr; 119(7):945-950. PubMed ID: 28139221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
    Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
    Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
    J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
    Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
    Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein (a) and comprehensive lipid tetrad index as a marker for coronary artery disease in NIDDM patients in South India.
    Rajappa M; Sridhar MG; Balachander J; Sethuraman KR
    Clin Chim Acta; 2006 Oct; 372(1-2):70-5. PubMed ID: 16701602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease.
    Dai W; Long J; Cheng Y; Chen Y; Zhao S
    Sci Rep; 2018 May; 8(1):7726. PubMed ID: 29769559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease.
    Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Hong LF; Li JJ
    Heart; 2020 Aug; 106(16):1228-1235. PubMed ID: 32381650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint Association of Lipoprotein(a) and a Family History of Coronary Artery Disease with the Cardiovascular Outcomes in Patients with Chronic Coronary Syndrome.
    Liu HH; Li S; Zhang Y; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Dong Q; Li JJ
    J Atheroscler Thromb; 2024 Sep; 31(9):1319-1332. PubMed ID: 38616111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.
    Ezhov MV; Safarova MS; Afanasieva OI; Kukharchuk VV; Pokrovsky SN
    Atherosclerosis; 2014 Aug; 235(2):477-82. PubMed ID: 24952151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.
    Leistner DM; Laguna-Fernandez A; Haghikia A; Abdelwahed YS; Schatz AS; Erbay A; Roehle R; Fonseca AF; Ferber P; Landmesser U
    Eur J Prev Cardiol; 2024 May; 31(7):856-865. PubMed ID: 38348689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.
    Liu C; Xu MX; He YM; Zhao X; Du XJ; Yang XJ
    Acta Diabetol; 2017 May; 54(5):443-453. PubMed ID: 28132096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
    Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD
    J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate.
    Reinhard H; Hansen PR; Persson F; Tarnow L; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Nephrol Dial Transplant; 2011 Oct; 26(10):3242-9. PubMed ID: 21372253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.